Smith & Nephew SNATS, Inc. (SNN): Price and Financial Metrics

Smith & Nephew SNATS, Inc. (SNN): $35.51

-0.54 (-1.50%)

POWR Rating

Component Grades














  • SNN scores best on the Value dimension, with a Value rank ahead of 92.71% of US stocks.
  • The strongest trend for SNN is in Growth, which has been heading up over the past 52 weeks.
  • SNN's current lowest rank is in the Momentum metric (where it is better than 24.92% of US stocks).

SNN Stock Summary

  • SNN has a market capitalization of $15,950,059,281 -- more than approximately 85.35% of US stocks.
  • With a year-over-year growth in debt of 74.21%, Smith & Nephew Plc's debt growth rate surpasses 89.53% of about US stocks.
  • Revenue growth over the past 12 months for Smith & Nephew Plc comes in at -11.25%, a number that bests merely 16.79% of the US stocks we're tracking.
  • Stocks that are quantitatively similar to SNN, based on their financial statements, market capitalization, and price volatility, are TFX, JOUT, IOSP, VTRS, and BRC.
  • SNN's SEC filings can be seen here. And to visit Smith & Nephew Plc's official web site, go to

SNN Valuation Summary

  • SNN's price/earnings ratio is 37.9; this is 3.84% higher than that of the median Healthcare stock.
  • Over the past 230 months, SNN's price/sales ratio has gone up 2.5.
  • Over the past 230 months, SNN's price/earnings ratio has gone up 25.8.

Below are key valuation metrics over time for SNN.

Stock Date P/S P/B P/E EV/EBIT
SNN 2021-08-31 3.7 3.2 37.9 62.2
SNN 2021-08-30 3.7 3.2 38.0 62.3
SNN 2021-08-27 3.7 3.2 38.1 62.4
SNN 2021-08-26 3.8 3.2 38.3 62.7
SNN 2021-08-25 3.8 3.2 38.5 63.1
SNN 2021-08-24 3.8 3.2 38.4 62.9

SNN Growth Metrics

  • The year over year cash and equivalents growth rate now stands at 299.71%.
  • Its 5 year net cashflow from operations growth rate is now at 13.88%.
  • The 3 year revenue growth rate now stands at 5.83%.
Over the past 30 months, SNN's revenue has gone down $343,999,436.

The table below shows SNN's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 4,560.001 972.0003 448.0001
2020-12-31 4,560 972 448
2020-12-31 4,560 972 448
2020-06-30 5,138 1,370 599.9998
2019-12-31 5,138 1,370 600
2019-12-31 5,138 1,370 600

SNN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • SNN has a Quality Grade of B, ranking ahead of 77.88% of graded US stocks.
  • SNN's asset turnover comes in at 0.445 -- ranking 106th of 186 Medical Equipment stocks.
  • HOLX, BIOL, and TTOO are the stocks whose asset turnover ratios are most correlated with SNN.

The table below shows SNN's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-07-03 0.445 0.694 0.050
2020-12-31 0.449 0.694 0.051
2020-12-31 0.449 0.694 0.051
2020-06-27 0.556 0.740 0.146
2019-12-31 0.592 0.740 0.174
2019-12-31 0.592 0.740 0.174

SNN Stock Price Chart Interactive Chart >

Price chart for SNN

SNN Price/Volume Stats

Current price $35.51 52-week high $46.10
Prev. close $36.05 52-week low $33.49
Day low $35.51 Volume 271,100
Day high $36.05 Avg. volume 505,200
50-day MA $36.53 Dividend yield 1.55%
200-day MA $40.25 Market Cap 15.61B

Smith & Nephew SNATS, Inc. (SNN) Company Bio

Smith & Nephew plc develops, manufactures, markets, and sells medical devices in the advanced surgical devices and advanced wound management sectors worldwide. The Company operates in two segments: Advanced Surgical Devices and Advanced Wound Management. The company was founded in 1856 and is based in London, the United Kingdom.

SNN Latest News Stream

Event/Time News Detail
Loading, please wait...

SNN Latest Social Stream

Loading social stream, please wait...

View Full SNN Social Stream

Latest SNN News From Around the Web

Below are the latest news stories about Smith & Nephew Plc that investors may wish to consider to help them evaluate SNN as an investment opportunity.

Amniotic Membrane Market is Going to Boom 2021-2028 | Top Players Smith & Nephew, Applied Biologics, Organogenesis Holdings

New Study Reports Amniotic Membrane Market 2021, Global Key Players Analysis, Share, Trends, Business Updates, Future Opportunities Forecasts to 2028 has been Added. In terms of revenue, the global Amniotic Membrane market was valued at US$ 3,201.1 Mn

OpenPR | October 26, 2021

PEAK6 Investments LLC Takes $276,000 Position in Smith & Nephew plc (NYSE:SNN)

PEAK6 Investments LLC bought a new stake in Smith & Nephew plc (NYSE:SNN) in the 2nd quarter, reports. The firm bought 6,364 shares of the medical equipment providers stock, valued at approximately $276,000. Several other institutional investors and hedge funds have also recently modified their holdings of SNN. Whittier Trust Co. of Nevada Inc. []

Dakota Financial News | October 26, 2021

Smith+Nephew's IODOSORB™ Range shown more than twice as likely to heal wounds than standard care

Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology business, is pleased to announce the results of a systematic review and meta-analysis of comparative trials to determine the efficacy of its IODOSORB 0.9% Cadexomer Iodine Range* on chronic wounds versus standard care specific to the wound type.1

Yahoo | October 26, 2021

Reviewing Advanced Biomedical Technologies (OTCMKTS:ABMT) & Smith & Nephew (NYSE:SNN)

Advanced Biomedical Technologies (OTCMKTS:ABMT) and Smith & Nephew (NYSE:SNN) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, risk, valuation and earnings. Volatility and Risk Advanced Biomedical Technologies has a beta of -1.13, suggesting that its []

Transcript Daily | October 25, 2021

Medical Videoscope Market 2021: Comprehensive Study by Key Players - Olympus, Stryker, Karl Storz, Fujifilm, Richard Wolf, Smith & Nephew | Foreseen Till 2028

Overview of Global Medical Videoscope Market: Medical Videoscope Market research report has been created with the systematic gathering and evaluation of Market information for Healthcare industry which is presented in a form that explains various facts and figures to the business.

OpenPR | October 22, 2021

Read More 'SNN' Stories Here

SNN Price Returns

1-mo -0.38%
3-mo -12.55%
6-mo -17.09%
1-year 1.60%
3-year 16.06%
5-year 31.40%
YTD -14.11%
2020 -10.45%
2019 30.78%
2018 8.84%
2017 18.54%
2016 -13.98%

SNN Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full SNN Dividend History

Continue Researching SNN

Here are a few links from around the web to help you further your research on Smith & Nephew Plc's stock as an investment opportunity:

Smith & Nephew Plc (SNN) Stock Price | Nasdaq
Smith & Nephew Plc (SNN) Stock Quote, History and News - Yahoo Finance
Smith & Nephew Plc (SNN) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.9827 seconds.